Ketamine-induced biliary dilatation
- Type
- Disease
- Group
- Disorder
- Inheritance
- Not applicable
- Age of onset
- All ages
- Status
- active
Ketamine-induced biliary dilatation is an acquired biliary tract disease caused by the abusive consumption of ketamine, which results in the fusiform dilatation of the common bile ducts (CBD) without obstructive lesions or dilatation of the intrahepatic biliary ducts. Possible manifestations of the underlying cholangiopathy include epigastric pain and impaired liver function. Severity of CBD dilatation appears to correlate with the duration of ketamine consumption and the condition has been reported to be reversible in abstinent patients.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Ketamine-induced biliary dilatation | |
| fr | Dilatation des voies biliaires induite par la kétamine | |
| de | Gallengangdilatation, Ketamine-induzierte | |
| es | Dilatación biliar inducida por ketamina | |
| it | Dilatazione biliare indotta dalla ketamina | |
| nl | Ketaminegeïnduceerde galdilatatie | |
| pt | Dilatação biliar induzida por quetamina | |
| pl | Rozszerzenie przewodów żółciowych wzbudzane ketaminą | |
| cs | Ketaminem indukovaná dilatace žlučových cest | |
| uk | Дилатація жовчовивідних шляхів, спричинена кетаміном | |
| zh | 氯胺酮诱导的胆管扩张 | |
| tr | Ketamin-kaynaklı biliyer dilatasyon |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-10 | X44 | NTBT | attributed | validated |
| ICD-11 | NE60 | NTBT | attributed | validated |
| MONDO | 0017394 | E | validated | |
| UMLS | C4512018 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:306640Rare intoxication due to medical products
rare disorders due to toxic effects
No children.
Genes
0 directOrphanet records no gene directly on this code.
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Cases/families | 2 cases | Worldwide | Case(s) | Validated | 22124288[PMID] | |
| Point prevalence | Unknown | — | Worldwide | Class only | Validated | ORPHANET_22124288[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
4 annotations · validated 2016-10-27| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0002027 | Abdominal pain | |
| HP:0012440 | Abnormal biliary tract morphology | |
| HP:0100518 | Dysuria | |
| HP:0000738 | Hallucinations | |
Run the differential on the 4 obligate / very frequent terms
Annotation source: 22124288[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/293807
- This record as JSON: /data/d/293807.json